TRAC developed a proprietary model that uses AI to predict which early-stage startups are most likely to be valued at more than $1 billion.
Objective Autoimmune rheumatic diseases, including rheumatoid arthritis (RA), have recently been associated with an increased risk of cancer, particularly head and neck cancer (HNC). This study aimed ...